Immunogen, Inc. (IMGN) Misses Q3 Expectations
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
License and milestone fees: 76K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
License and milestone fees: 76K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.44), $0.17 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $13.28 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
